Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer
Latest Information Update: 17 Aug 2020
At a glance
- Drugs IMM 101 (Primary)
- Indications Pancreatic cancer
- Focus Expanded access; Therapeutic Use
Most Recent Events
- 12 Aug 2020 Status changed from recruiting to completed.
- 31 Oct 2019 New trial record